Article
BRCA mutations and the risk of angiosarcoma after breast cancer treatment.
Clinical breast cancer - 1 Dec 2008
West John G, Weitzel Jeffrey N, Tao May Lin, Carpenter Michele, West Justin E, Fanning Caitlin
Abstract excerpt
Post-breast cancer treatment-related angiosarcomas were first observed in lymphedematous extremities after mastectomy and are now being reported with increasing frequency after lumpectomy and radiation. A case history is presented of a BRCA2 carrier who had a postmastectomy chest wall angiosarcoma but had neither therapeutic radiation nor clinically evident lymphedema. The absence of established risk factors led...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
